David Alan Campbell - 10 Jun 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role: Chief Executive Officer, Director
Signature: /s/ David Campbell
Issuer symbol: JANX
Transactions as of: 10 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 10 Jun 2021, 19:02:10 UTC
Next filing: 05 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	JANX	Common Stock						332,054	10 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	JANX	Stock Option (right to buy)							10 Jun 2021	Common Stock	64,050	$0.1100	Direct	F1
holding	JANX	Stock Option (right to buy)							10 Jun 2021	Common Stock	448,350	$0.5940	Direct	F2
holding	JANX	Stock Option (right to buy)							10 Jun 2021	Common Stock	704,550	$4.21	Direct	F3
holding	JANX	Stock Option (right to buy)							10 Jun 2021	Common Stock	727,608	$10.59	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares vest one year after January 16, 2020 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase.
F2	1/4th of the shares vest one year after June 30, 2020 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase.
F3	1/4th of the shares vest one year after March 10,2021 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase.
F4	1/4th of the shares vest one year after May 14, 2021 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase.